Evidence map›Paper›PMID 34186345›Full record

Observational studyDiabetes & metabolic syndrome

Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India.

Arun Raghavan, Arun Nanditha, Krishnamoorthy Satheesh, Priscilla Susairaj, Ramachandran Vinitha, Sruti Chandrasekaran, Thiruppathy Palaniappan, Su Thillai Vallal, A Subair Khan, Chamukuttan Snehalatha and 1 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Diabetes and SARS-CoV-2-Is There a Mutual Connection?Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Arun RaghavanIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Arun NandithaIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Krishnamoorthy SatheeshIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Priscilla SusairajIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Ramachandran VinithaIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Sruti ChandrasekaranDr. Rela Institute and Medical Centre, Chennai, India.
Thiruppathy PalaniappanMedway Hospitals, Chennai, India.
Su Thillai VallalVenkataeswara Hospitals, Chennai, India.
A Subair KhanOrthomed Hospital, Chennai, India.
Chamukuttan SnehalathaIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India.
Ambady RamachandranIndia Diabetes Research Foundation and Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India. Electronic address: dr.ramachandran@ardiabetes.org.
India Diabetes Research Foundation · INApollo Hospitals · INGovernment Hospital of Thoracic Medicine · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsWe studied the profile and outcome of patients hospitalized for coronavirus disease-19 (COVID-19) infection with and without type 2 diabetes (T2DM).

methodsIn this observational study, clinical details of patients with COVID-19, identified by Reverse Transcription - Polymerase Chain Reaction admitted to 4 hospitals in Chennai, Tamil Nadu, India were collected from May to November 2020. A total of 845 (n = 423 with diabetes, n = 422 without diabetes) were selected for the analysis. Clinical details, biochemical and radiological investigations, diabetes treatment, intensive care, mortality and other adverse outcomes were recorded. Patients with clinical history of T2DM, glycosylated haemoglobin (HbA1c) of ≥6.5% (48 mmol/mol) and/or random blood glucose ≥200 mg/dl (11.1 mmol/l) were included. Statistical analyses were done using chi-square or 't' test and multiple logistic regression analysis.

resultsAt admission, patients with T2DM were older (p < 0.0001), had higher co-morbidities such as coronary artery disease (p = 0.02), hypertension (p < 0.0001), hypothyroidism (p = 0.03) and renal disorders (p = 0.01) than non-diabetes persons. Requirement for intensive care was higher among them. Acute renal injury or failure, pneumonia and myocardial infarction developed in higher percentage of T2DM. Mortality was significantly higher in T2DM (10.2% vs 5.9%, p = 0.02). However, in the multiple logistic regression analysis, only age (p < 0.0001) and renal disorders (p = 0.002) were significantly associated with mortality.

conclusionOur study showed that mortality was associated with higher age and renal disorders but did not show an association with diabetes, among patients hospitalized for COVID-19 infection.

Indexed as

Case-Control StudiesCOVID-19Diabetes Mellitus, Type 2FemaleHospitalizationHumansIndiaMaleMiddle AgedPrognosisRisk FactorsSARS-CoV-2Adverse outcomesAsian indiansCOVID-19 and diabetes

Identifiers

PMID34186345
PMCPMC8146270
OpenAlexW3165592570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.